Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Long-Term Deferred Tax: 2020-2023

Historic Long-Term Deferred Tax for Maravai Lifesciences Holdings (MRVI) over the last 3 years, with Sep 2023 value amounting to $773.7 million.

  • Maravai Lifesciences Holdings' Long-Term Deferred Tax rose 0.33% to $773.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $773.7 million, marking a year-over-year increase of 0.33%. This contributed to the annual value of $765.8 million for FY2022, which is 5.24% down from last year.
  • According to the latest figures from Q3 2023, Maravai Lifesciences Holdings' Long-Term Deferred Tax is $773.7 million, which was up 0.53% from $769.6 million recorded in Q2 2023.
  • Maravai Lifesciences Holdings' 5-year Long-Term Deferred Tax high stood at $820.8 million for Q3 2021, and its period low was $419.9 million during Q1 2021.
  • Moreover, its 3-year median value for Long-Term Deferred Tax was $771.1 million (2022), whereas its average is $730.9 million.
  • Within the past 5 years, the most significant YoY rise in Maravai Lifesciences Holdings' Long-Term Deferred Tax was 88.90% (2022), while the steepest drop was 6.05% (2022).
  • Quarterly analysis of 4 years shows Maravai Lifesciences Holdings' Long-Term Deferred Tax stood at $431.7 million in 2020, then soared by 87.19% to $808.1 million in 2021, then declined by 5.24% to $765.8 million in 2022, then grew by 0.33% to $773.7 million in 2023.
  • Its Long-Term Deferred Tax was $773.7 million in Q3 2023, compared to $769.6 million in Q2 2023 and $767.0 million in Q1 2023.